Media briefing on COVID-19 and World Immunization Week - 26/04/2021
Date:
26/04/2021
00:00:30
CL Hello and good day to wherever you are listening to us today. It's Monday 26th April 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference with a special focus on the impact of COVID-19 on immunisation as we mark World Immunization Week, which started on Saturday 24th April.
The press conference will include two special guests...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Americas/epidemiology, Immunization Programs/organization & administration, Epidemiological Monitoring, Risk Groups, Health Systems/organization & administration, Health Equity, Quarantine/organization & administration, Social Isolation, Strategic Stockpile/organization & administration, Dissolved Oxygen, Health Consortia, Access to Essential Medicines and Health Technologies, Sustainable Development, Gift Giving, Healthcare Financing, COVID-19, Covax, Ghebreyesus, Tedros Adhanom
Media briefing on COVID-19 - 06/04/2021
Date:
06/04/2021
00:00:17
CL Hello, good day and welcome, wherever you are listening today. It is Tuesday 6th April 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference ahead of World Health Day, which we celebrate on 7th April.
Therefore we have a list of very special guests online with us today. We'll start with Her Excellency Prime Minister Mia Mottley...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Health Equity, Oxygen/supply & distribution, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Health Consortia, Risk Groups, Access to Essential Medicines and Health Technologies, Healthcare Financing, Health Systems/economics, Vulnerable Populations, Universal Health Insurance, Health Information Systems, Epidemiological Monitoring, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 05/01/2021
Date:
05/01/2021
00:00:00
FC Hello, all. This is Fadela Chaib speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Tuesday 5th January, our first press briefing of 2021. I'm sorry for the delay and thank you for your patience. The focus today will be on COVID-19 but we will also brief you on the outcome of today's virtual meeting of SAGE, the strategic...
See more details
Health Services Accessibility/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Health Personnel, Epidemiological Monitoring, Noncommunicable Diseases/prevention & control, Health Systems, Social Isolation, Risk Groups, Health Consortia, Immunization Programs/organization & administration, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 08/01/2021
Date:
08/01/2021
00:00:54
FC Hello, all. I think our technical problems are being solved now. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and I welcome you to our global COVID-19 press conference today, Friday 8th January. Present in the room are WHO Director-General, Dr Tedros, Dr Mike Ryan, Executive Director, Health Emergencies, Dr Maria Van Kerkhove, Technical Lead for COVID-19,...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/statistics & numerical data, Americas/epidemiology, Viral Vaccines/supply & distribution, Health Consortia, Access to Essential Medicines and Health Technologies, Healthcare Financing, Health Systems/organization & administration, Health Personnel, Risk Groups, Social Isolation, Masks, Quarantine, Epidemiological Monitoring, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 15/01/2021
Date:
15/01/2021
00:00:00
FC Hello, all. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Friday 15th January. We will update you about COVID-19 but also about the recommendation of the sixth emergency committee meeting regarding the outbreak of COVID-19 that took place virtually yesterday. The emergency committee stateme...
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Risk Groups, Health Systems, Epidemiological Monitoring, Oxygen/supply & distribution, Refugees, Access to Essential Medicines and Health Technologies, Health Equity, Betacoronavirus/genetics, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 15/03/2021
Date:
15/03/2021
00:00:24
CL Hello and good day wherever you are joining us today. It is Monday 15th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference with a special focus on the first anniversary of the COVID-19 Solidarity Response Fund.
Simultaneous translation is provided in the six official languages, Arabic, Chinese, French, English, Spanish...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Financial Resources in Health/economics, Risk Groups, Viral Vaccines/adverse effects, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Quarantine, Health Systems, Vaccine Potency, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 01/04/2021
Date:
01/04/2021
00:00:49
CL Good day. Hello and welcome, wherever you are listening to us today. It is Thursday 1st April 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference with a special focus on the impact of COVID-19, the success of the ACT Accelerator and the work needed to support equity, especially for the health workforce.
For this we welcome two special...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Noncommunicable Diseases/prevention & control, 57445, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Financial Resources in Health/economics, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation/psychology, Quarantine/psychology, Social Stigma, Oxygen/supply & distribution, Health Systems/organization & administration, Hospital Bed Capacity, Intensive Care Units, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 16/10/2020
Date:
16/10/2020
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Health Systems/organization & administration, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Chloroquine/therapeutic use, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Clinical Protocols, Dexamethasone/therapeutic use, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Clinical Trial, Health Equity, Americas/epidemiology, Social Isolation, Masks, Hospital Bed Capacity, Intensive Care Units, Influenza, Human/immunology, Influenza Vaccines/immunology, Risk Groups, Health Promotion, Hypertension/prevention & control, COVID-19, Ghebreyesus, Tedros Adhanom, Covax
EBSpecial on COVID-19
Date:
06/10/2020
See more details
Betacoronavirus/immunology, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Pneumonia, Viral/epidemiology, Pneumonia, Viral/diagnosis, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Health Systems/organization & administration, Security Measures/standards, Epidemiological Monitoring, Health Personnel/organization & administration, Vulnerable Populations, Risk Groups, World Health Organization/organization & administration, Pandemics/prevention & control, Personal Protective Equipment/supply & distribution, Health Services Accessibility/organization & administration, Disease Transmission, Infectious/prevention & control, Social Isolation, Quarantine/organization & administration, Clinical Protocols/standards, Universal Access to Health Care Services, Access to Essential Medicines and Health Technologies, COVID-19, Covax
live from UNGA side event on infodemic management with Dr Tedros
Date:
23/09/2020
See more details
Coronavirus Infections/transmission, Coronavirus Infections/diagnosis, Coronavirus Infections/epidemiology, Pneumonia, Viral/transmission, Pneumonia, Viral/diagnosis, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Communication, Health Promotion, Online Social Networking, News, Health Communication, Health Information Management/organization & administration, Self Medication/adverse effects, Health Personnel/organization & administration, Risk Groups, Health Systems/organization & administration, COVID-19, Ghebreyesus, Tedros Adhanom , Infodemia, Fake news
